Browsing "Obstetrics and Gynaecology publications" by Author Tajik, P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 7 to 13 of 13 < previous 
PreviewIssue DateTitleAuthor(s)
2015Relevance of individual participant data meta-analysis for studies in obstetrics: delivery versus expectant monitoring for hypertensive disorders of pregnancyBroekhuijsen, K.; Bernardes, T.; van Baaren, G.; Tajik, P.; Novikova, N.; Thangaratinam, S.; Boers, K.; Koopmans, C.; Wallace, K.; Shennan, A.; Langenveld, J.; Groen, H.; van den Berg, P.; Mol, B.; Franssen, M.
2012Should cervical favourability play a role in the decision for labour induction in gestational hypertension or mild pre-eclampsia at term? An exploratory analysis of the HYPITAT trialTajik, P.; van der Tuuk, K.; Koopmans, C.; Groen, H.; van Pampus, M.; van der Berg, P.; van der Post, J.; van Loon, A.; de Groot, C.; Kwee, A.; Huisjes, A.; van Beek, E.; Papatsonis, D.; Bloemenkamp, K.; van Unnik, G.; Porath, M.; Rijnders, R.; Stigter, R.; de Boer, K.; Scheepers, L.; et al.
2013Trial designs for personalizing cancer care: a systematic review and classificationTajik, P.; Zwinderman, A.; Mol, B.; Bossuyt, P.
2019Tubal flushing with oil- or water-based contrast medium: can we identify markers that indicate treatment benefit?van Rijswijk, J.; van Welie, N.; Dreyer, K.; Tajik, P.; Lambalk, C.B.; Hompes, P.; Mijatovic, V.; Mol, B.W.J.; Zafarmand, M.H.
2011Using a simplified Bishop score to predict vaginal deliveryTajik, P.; Bossuyt, P.M.; Mol, B.W.
2014Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trialsTajik, P.; van der Ham, D.; Zafarmand, M.; Hof, M.; Morris, J.; Franssen, M.; de Groot, C.; Duvekot, J.; Oudijk, M.; Willekes, C.; Bloemenkamp, K.; Porath, M.; Woiski, M.; Akerboom, B.; Sikkema, J.; Bijvank, B.; Mulder, A.; Bossuyt, P.; Mol, B.
2013Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trialvan Meurs, H.; Tajik, P.; Hof, M.; Vergote, I.; Kenter, G.; Mol, B.; Buist, M.; Bossuyt, P.